1. Home
  2. MRUS vs IBTX Comparison

MRUS vs IBTX Comparison

Compare MRUS & IBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • IBTX
  • Stock Information
  • Founded
  • MRUS 2003
  • IBTX 2002
  • Country
  • MRUS Netherlands
  • IBTX United States
  • Employees
  • MRUS N/A
  • IBTX N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • IBTX Major Banks
  • Sector
  • MRUS Health Care
  • IBTX Finance
  • Exchange
  • MRUS Nasdaq
  • IBTX Nasdaq
  • Market Cap
  • MRUS 2.9B
  • IBTX 2.8B
  • IPO Year
  • MRUS 2016
  • IBTX 2013
  • Fundamental
  • Price
  • MRUS $44.21
  • IBTX $64.79
  • Analyst Decision
  • MRUS Strong Buy
  • IBTX Buy
  • Analyst Count
  • MRUS 12
  • IBTX 7
  • Target Price
  • MRUS $87.92
  • IBTX $61.00
  • AVG Volume (30 Days)
  • MRUS 635.1K
  • IBTX 269.1K
  • Earning Date
  • MRUS 10-31-2024
  • IBTX 01-21-2025
  • Dividend Yield
  • MRUS N/A
  • IBTX 2.36%
  • EPS Growth
  • MRUS N/A
  • IBTX N/A
  • EPS
  • MRUS N/A
  • IBTX N/A
  • Revenue
  • MRUS $35,932,000.00
  • IBTX $466,720,000.00
  • Revenue This Year
  • MRUS N/A
  • IBTX N/A
  • Revenue Next Year
  • MRUS $57.37
  • IBTX $24.13
  • P/E Ratio
  • MRUS N/A
  • IBTX N/A
  • Revenue Growth
  • MRUS N/A
  • IBTX N/A
  • 52 Week Low
  • MRUS $24.95
  • IBTX $36.47
  • 52 Week High
  • MRUS $61.61
  • IBTX $68.66
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 43.33
  • IBTX 44.62
  • Support Level
  • MRUS $41.03
  • IBTX $63.42
  • Resistance Level
  • MRUS $43.68
  • IBTX $68.25
  • Average True Range (ATR)
  • MRUS 2.28
  • IBTX 1.44
  • MACD
  • MRUS 0.14
  • IBTX -0.57
  • Stochastic Oscillator
  • MRUS 29.61
  • IBTX 9.11

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About IBTX Independent Bank Group Inc

Independent Bank Group Inc is a bank holding company. It offers services such as checking and savings accounts, debit cards, online banking, including online account opening, mobile banking, eStatements and bank-by-mail and direct deposit services. The Company also offers business accounts and management services, including analyzed business checking, business savings, and treasury management services. The Company derives its income principally from interest earned on loans and, to a lesser extent, income from securities available for sale and securities held to maturity. The Company also derives income from noninterest sources, such as fees received in connection with various deposit services, mortgage banking operations and investment advisory services.

Share on Social Networks: